Wellness and the Role of Comorbidities in Multiple Sclerosis

被引:47
作者
Moss, Brandon P. [1 ]
Rensel, Mary R. [1 ]
Hersh, Carrie M. [2 ]
机构
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA
关键词
Wellness; Lifestyle medicine; Obesity; Vascular comorbidities; Psychiatric comorbidities; Multiple sclerosis; QUALITY-OF-LIFE; ARYL-HYDROCARBON RECEPTOR; T-LYMPHOCYTE ACTIVATION; ADVERSE LIPID PROFILE; HEART-DISEASE RISK; VITAMIN-D LEVELS; HEALTH BEHAVIORS; DOUBLE-BLIND; 1,25-DIHYDROXYVITAMIN D-3; DISABILITY PROGRESSION;
D O I
10.1007/s13311-017-0563-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disorder of the central nervous system, for which disease modifying therapies (DMTs) are the mainstay treatment approach to reduce inflammatory disease activity and slow worsening disability. In addition to conventional pharmacologic therapy, there is growing interest in the use of lifestyle strategies to support wellness and mitigate disease-related complications in MS. This interest stems from a growing appreciation of the role of certain comorbidities and lifestyle factors on disease activity, disability, mortality, and overall quality of life. While the current literature is not conclusive, there is evidence to suggest a potential role for vitamin D supplementation, tobacco smoking cessation, routine exercise, a plant-based, anti-inflammatory diet, and maintenance of emotional well-being as adjunct therapies to DMTs. In addition to DMTs, lifestyle strategies should be emphasized as part of a management plan focused on overall health and well-being.
引用
收藏
页码:999 / 1017
页数:19
相关论文
共 173 条
[1]  
Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268
[2]   Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists [J].
Adorini, Luciano ;
Penna, Giuseppe .
HUMAN IMMUNOLOGY, 2009, 70 (05) :345-352
[3]   Non pharmacological interventions for spasticity in multiple sclerosis [J].
Amatya, Bhasker ;
Khan, Fary ;
La Mantia, Loredana ;
Demetrios, Marina ;
Wade, Derick T. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02)
[5]  
[Anonymous], 2013, LIFESTYLE MED
[6]   Depressed mood in multiple sclerosis: Relationship to capacity-demanding memory and attentional functioning [J].
Arnett, PA ;
Higginson, CI ;
Voss, WD ;
Wright, B ;
Bender, WI ;
Wurst, JM ;
Tippin, JP .
NEUROPSYCHOLOGY, 1999, 13 (03) :434-446
[7]   Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression [J].
Ascherio, Alberto ;
Munger, Kassandra L. ;
White, Rick ;
Koechert, Karl ;
Simon, Kelly Claire ;
Polman, Chris H. ;
Freedman, Mark S. ;
Hartung, Hans-Peter ;
Miller, David H. ;
Montalban, Xavier ;
Edan, Gilles ;
Barkhof, Frederik ;
Pleimes, Dirk ;
Radue, Ernst-Wilhelm ;
Sandbrink, Rupert ;
Kappos, Ludwig ;
Pohl, Christoph .
JAMA NEUROLOGY, 2014, 71 (03) :306-314
[8]   Th17 Cells in Immunity and Autoimmunity [J].
Bedoya, Simone Kennedy ;
Lam, Brandon ;
Lau, Kenneth ;
Larkin, Joseph, III .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013, :986789
[9]   Integrative medicine and systemic outcomes research - Issues in the emergence of a new model for primary health care [J].
Bell, IR ;
Caspi, O ;
Schwartz, GER ;
Grant, KL ;
Gaudet, TW ;
Rychener, D ;
Maizes, V ;
Weil, A .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :133-140
[10]   SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN-D3 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRESENCE IN MONOCYTES AND INDUCTION IN LYMPHOCYTES-T FOLLOWING ACTIVATION [J].
BHALLA, AK ;
AMENTO, EP ;
CLEMENS, TL ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (06) :1308-1310